[1]
K. Dev, J. Begum, N. A. Mir, and R. Kant, “Advancements of CRISPR/Cas9 technology and its value in antiviral therapeutics: CRISPR/Cas9 in antiviral therapeutics”, Lett. Anim. Biol., vol. 1, no. 1, pp. 46–57, Sep. 2021.